Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

IM Cannabis Corp C.IMCC

Alternate Symbol(s):  IMCC

IM Cannabis Corp. is a Canada-based international cannabis company that provides cannabis products to medical patients in Israel and Germany. The Company's ecosystem operates in Israel through its commercial relationship with Focus Medical Herbs Ltd., which imports and distributes cannabis to medical patients, leveraging proprietary data and patient insights. The Company also operates medical cannabis retail pharmacies, online platforms, distribution centers, and logistical hubs in Israel. In Germany, the Company operates through Adjupharm GmbH, where it distributes cannabis to pharmacies for medical cannabis patients. It offers four different product lines, leading with the Craft Collection which offers the highest quality Canadian craft cannabis flower. The Company's other product lines include Top-Shelf Collection, Signature Collection and Full Spectrum Extracts. The Company's brands include The WAGNERS, BLKMKT, LOT420, and The PICO collection (minis).


CSE:IMCC - Post by User

Comment by RockMaschineon Apr 26, 2022 11:10am
213 Views
Post# 34632141

RE:MYM Nutraceuticals Should Not Have Joined IM Cannabis

RE:MYM Nutraceuticals Should Not Have Joined IM Cannabis
Yet again big old Moose doesn't have a sweet clue as to the relationship between the three companies. Remove Biome from your drivel, they are out of the picture. Biome owned Highland Grow and started it all. Highland Grow was sold to MYM which was then acquired by IMCC. As to Nasdaq delisting, should the share price drop below $1US for an extended period of time they will be issued a warning and then have up to 90 days to bring the price back up. CEO Oren Schuster just acquired $450 000 worth of stock at an average price of $2.80. Likely the shares have been leveraged by a broker to do things in the market. Take advantage and buy at a discount to the man who has a frontline view of the company's direction. If you listened to the conference call you would have heard the CFO project profitable operations exiting Q2. $14 million of cash on hand and no plans for any new acquisitions. $29 million on balance sheet listed in inventory so expect a bit less than that reported for revenue soon. The opportunity is here to buy this for 1x revenue on the cusp of significant growth through the remainder of the year. All stocks in the sector are down and still joined at the hip. ETF MSOS is the leading indicator and until things change we are stuck. 69 MILLION shares outstanding and a high volume day is 50-70 thousand, ha. I have no idea why you still bring up FSD pharma as that has no relevance to this company and continues to show your ignorance.
<< Previous
Bullboard Posts
Next >>